Capricor Therapeutics' Series A Round

Capricor Therapeutics raised a round of funding on December 20, 2010. Investors include Broadview Ventures.

Capricor Therapeutics is a privately held biotechnology company that aims to create powerful, yet easy-to-administer cardiac stem cell treatments to regenerate damaged heart muscle and improve heart f…

Articles about Capricor Therapeutics' Series A Round: